{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:59:21Z","timestamp":1788919161762,"version":"build-2803163510"},"reference-count":163,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.cardfail.2013.04.002","type":"journal-article","created":{"date-parts":[[2013,6,3]],"date-time":"2013-06-03T07:56:53Z","timestamp":1370246213000},"page":"371-389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Acute Decompensated Heart Failure: Update on New and Emerging Evidence and Directions for Future Research"],"prefix":"10.1016","volume":"19","author":[{"given":"Michael M.","family":"Givertz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Teerlink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy M.","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl A.","family":"Westlake Canary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean P.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Colvin-Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin A.","family":"Ezekowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian F.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart D.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajan","family":"Krishnamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy Gattis","family":"Stough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary N.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter E.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Dimarco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray E.","family":"Hershberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph G.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Spertus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy K.","family":"Sweitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.H.","family":"Wilson Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall C.","family":"Starling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2013.04.002_bib1","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1067\/mhj.2003.150","article-title":"The problem of decompensated heart failure: nomenclature, classification, and risk stratification","volume":"145","author":"Felker","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2013.04.002_bib2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cardfail.2010.04.004","article-title":"HFSA 2010 comprehensive heart failure practice guideline","volume":"16","author":"Lindenfeld","year":"2010","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2013.04.002_bib3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.11.013","volume":"53","author":"Hunt","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.04.002_bib4","first-page":"1","article-title":"Hospitalization for congestive heart failure: United States, 2000\u20132010","volume":"108","author":"Hall","year":"2012","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.cardfail.2013.04.002_bib5","first-page":"e2","article-title":"Heart disease and stroke statistics\u20142012 update: a report from the American Heart Association","volume":"125","author":"Roger","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2013.04.002_bib6","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/jama.2011.1474","article-title":"National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998\u20132008","volume":"306","author":"Chen","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2013.04.002_bib7","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/CIR.0b013e31820a55f5","article-title":"Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association","volume":"123","author":"Heidenreich","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2013.04.002_bib8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jacc.2012.09.038","article-title":"Rehospitalization for heart failure: problems and perspectives","volume":"61","author":"Gheorghiade","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.04.002_bib9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1100171","article-title":"Effect of nesiritide in patients with acute decompensated heart failure","volume":"365","author":"O\u2019Connor","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2013.04.002_bib10","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/archinte.167.14.1493","article-title":"Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF)","volume":"167","author":"Fonarow","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cardfail.2013.04.002_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ahj.2004.03.004","article-title":"Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF): rationale and design","volume":"148","author":"Fonarow","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2013.04.002_bib12","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00134-010-2113-0","article-title":"Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF)","volume":"37","author":"Follath","year":"2011","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cardfail.2013.04.002_bib13","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1161\/CIRCULATIONAHA.107.690768","article-title":"Patterns of weight change preceding hospitalization for heart failure","volume":"116","author":"Chaudhry","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2013.04.002_bib14","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/eurheartj\/ehl193","article-title":"EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population","volume":"27","author":"Nieminen","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2013.04.002_bib15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10741-011-9294-7","article-title":"Early changes in clinical characteristics after emergency department therapy for acute heart failure syndromes: identifying patients who do not respond to standard therapy","volume":"17","author":"Collins","year":"2012","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cardfail.2013.04.002_bib16","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1097\/01.CCM.0000296274.51933.4C","article-title":"Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes","volume":"36","author":"Mebazaa","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cardfail.2013.04.002_bib17","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(09)60622-X","article-title":"Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study","volume":"373","author":"Teerlink","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2013.04.002_bib18","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa0912613","article-title":"Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure","volume":"363","author":"Massie","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2013.04.002_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11897-010-0020-x","article-title":"Observation units in the management of\u00a0acute heart failure syndromes","volume":"7","author":"Fermann","year":"2010","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.cardfail.2013.04.002_bib20","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/eurjhf\/hfq185","article-title":"Trends in heart failure care: has the incident diagnosis of heart failure shifted from the hospital to the emergency department and outpatient clinics?","volume":"13","author":"Ezekowitz","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2013.04.002_bib21","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0140-6736(11)60101-3","article-title":"Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial","volume":"377","author":"Abraham","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2013.04.002_bib22","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1161\/CIRCULATIONAHA.108.783910","article-title":"Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures","volume":"118","author":"Zile","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2013.04.002_bib23","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cardfail.2009.01.012","article-title":"Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert","volume":"15","author":"Small","year":"2009","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2013.04.002_bib24","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1161\/CIRCULATIONAHA.107.696906","article-title":"Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure","volume":"116","author":"Solomon","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2013.04.002_bib25","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0195-668X(02)00823-0","article-title":"The EuroHeart Failure survey programme\u2014a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis","volume":"24","author":"Cleland","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2013.04.002_bib26","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0195-668X(02)00700-5","article-title":"The EuroHeart Failure Survey programme\u2014a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment","volume":"24","author":"Komajda","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2013.04.002_bib27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","article-title":"Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"149","author":"Adams","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2013.04.002_bib28","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2013.04.002_bib29","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.cardfail.2007.03.011","article-title":"High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database","volume":"13","author":"Heywood","year":"2007","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2013.04.002_bib30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000164149","article-title":"Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry","volume":"113","author":"Peacock","year":"2009","journal-title":"Cardiology"},{"key":"10.1016\/j.cardfail.2013.04.002_bib31","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ejheart.2007.07.011","article-title":"Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial","volume":"9","author":"Hasselblad","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2013.04.002_bib32","first-page":"331","article-title":"Relationship between heart failure treatment and development of worsening renal function among hospitalized patients","volume":"147","author":"Butler","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2013.04.002_bib33","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/eurjhf\/hfr121","article-title":"Impact of diuretic dosing on mortality in acute heart failure using a propensity-matched analysis","volume":"13","author":"Yilmaz","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2013.04.002_bib34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/CIRCULATIONAHA.109.933275","article-title":"Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival","volume":"122","author":"Testani","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2013.04.002_bib35","first-page":"CD003178","article-title":"Continuous infusion versus bolus injection of loop diuretics in congestive heart failure","author":"Salvador","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cardfail.2013.04.002_bib36","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.jacc.2005.01.059","article-title":"Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study","volume":"45","author":"Paterna","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.04.002_bib37","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1067\/mhj.2003.166","article-title":"Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects","volume":"145","author":"Licata","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2013.04.002_bib38","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1388-9842(00)00094-5","article-title":"Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure","volume":"2","author":"Paterna","year":"2000","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2013.04.002_bib39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/MAJ.0b013e31820f10ad","article-title":"Short-term effects of hypertonic saline solution in acute heart failure and long-term effects of a moderate sodium restriction in patients with compensated heart failure with New York Heart Association class III (class C) (SMAC-HF study)","volume":"342","author":"Paterna","year":"2011","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.cardfail.2013.04.002_bib40","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jacc.2006.07.073","article-title":"Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure","volume":"49","author":"Costanzo","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.04.002_bib41","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.jacc.2012.08.957","article-title":"Cardiorenal outcomes after slow continuous ultrafiltration therapy in refractory patients with advanced decompensated heart failure","volume":"60","author":"Patarroyo","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.04.002_bib42","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","article-title":"Ultrafiltration in decompensated heart failure with cardiorenal syndrome","volume":"367","author":"Bart","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2013.04.002_bib43","first-page":"1531","article-title":"Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial","volume":"287","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2013.04.002_bib44","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/01.CIR.0000159340.93220.E4","article-title":"Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure","volume":"111","author":"Sackner-Bernstein","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2013.04.002_bib45","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1001\/jama.293.15.1900","article-title":"Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials","volume":"293","author":"Sackner-Bernstein","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2013.04.002_bib46","unstructured":"Scios. Panel of cardiology experts provides recommendations to\u00a0Scios regarding NATRECOR. 2005. Available at: http:\/\/www sciosinc com\/scios\/pr_1118721302."},{"key":"10.1016\/j.cardfail.2013.04.002_bib47","series-title":"Goodman & Oilman's The Pharmacological Basis of Therapeutics","first-page":"277","article-title":"Adrenergic agonists and antagonists","author":"Westfall","year":"2011"},{"key":"10.1016\/j.cardfail.2013.04.002_bib48","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1097\/00003246-200108000-00005","article-title":"Use of dopamine in acute renal failure: a meta-analysis","volume":"29","author":"Kellum","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cardfail.2013.04.002_bib49","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/S0140-6736(00)03495-4","article-title":"Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial","volume":"356","author":"Bellomo","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2013.04.002_bib50","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/CIRCULATIONAHA.107.737106","article-title":"Renal vasodilatory action of dopamine in patients with heart failure: magnitude of effect and site of action","volume":"117","author":"Elkayam","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2013.04.002_bib51","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.cardfail.2010.07.246","article-title":"Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) trial","volume":"16","author":"Giamouzis","year":"2010","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2013.04.002_bib52","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1161\/hc1102.105264","article-title":"BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy","volume":"105","author":"Gottlieb","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2013.04.002_bib53","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ejheart.2008.01.010","article-title":"Adenosine and kidney function: potential implications in patients with heart failure","volume":"10","author":"Vallon","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2013.04.002_bib54","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1517\/14656560802682213","article-title":"Rolofylline: a selective adenosine 1 receptor antagonist for the treatment of heart failure","volume":"10","author":"Slawsky","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.cardfail.2013.04.002_bib55","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cardfail.2008.08.010","article-title":"The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment","volume":"14","author":"Cotter","year":"2008","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2013.04.002_bib56","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/j.jacc.2010.11.057","volume":"57","author":"Voors","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.04.002_bib57","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/11594680-000000000-00000","article-title":"The safety of an adenosine A(1)-receptor antagonist, rolofylline, in patients with acute heart failure and renal impairment: findings from PROTECT","volume":"35","author":"Teerlink","year":"2012","journal-title":"Drug Saf"},{"key":"10.1016\/j.cardfail.2013.04.002_bib58","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1161\/CIRCHEARTFAILURE.109.916072","article-title":"Adenosine A1 receptor antagonists at a fork in the road","volume":"2","author":"Givertz","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2013.04.002_bib59","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11897-010-0010-z","article-title":"Relaxin: review of biology and potential role in treating heart failure","volume":"7","author":"Teichman","year":"2010","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.cardfail.2013.04.002_bib60","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrcardio.2009.198","article-title":"Cardiovascular effects of relaxin: from basic science to clinical therapy","volume":"7","author":"Du","year":"2010","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cardfail.2013.04.002_bib61","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(12)61855-8","article-title":"Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial","volume":"381","author":"Teerlink","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2013.04.002_bib62","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","article-title":"Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial","volume":"287","author":"Cuffe","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2013.04.002_bib63","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1001\/jama.297.17.1883","article-title":"Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE randomized trial","volume":"297","author":"Mebazaa","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2013.04.002_bib64","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0002-8703(99)70250-4","article-title":"Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST)","volume":"138","author":"O\u2019Connor","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2013.04.002_bib65","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1056\/NEJM199812173392503","article-title":"A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure","volume":"339","author":"Cohn","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2013.04.002_bib66","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199111213252103","article-title":"Effect of oral milrinone on mortality in severe chronic heart failure","volume":"325","author":"Packer","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2013.04.002_bib67","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/hrt.72.3.226","article-title":"Treatment of severe heart failure: quantity or quality of life? A trial of enoximone","volume":"72","author":"Cowley","year":"1994","journal-title":"Br Heart J"},{"key":"10.1016\/j.cardfail.2013.04.002_bib68","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(11)61219-1","article-title":"Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man study","volume":"378","author":"Teerlink","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2013.04.002_bib69","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1126\/science.1200113","article-title":"Cardiac myosin activation: a potential therapeutic approach for systolic heart failure","volume":"331","author":"Malik","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.cardfail.2013.04.002_bib70","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0140-6736(11)61126-4","article-title":"The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial","volume":"378","author":"Cleland","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2013.04.002_bib71","doi-asserted-by":"crossref","first-page":"1239.e2","DOI":"10.1016\/j.ahj.2005.01.022","article-title":"Effects of the renal natriuretic peptide urodilatin (ularitide) in patients with decompensated chronic heart failure: a double-blind, placebo-controlled, ascending-dose trial","volume":"150","author":"Mitrovic","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2013.04.002_bib72","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1093\/eurheartj\/ehl337","article-title":"Haemodynamic and clinical effects of ularitide in decompensated heart failure","volume":"27","author":"Mitrovic","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2013.04.002_bib73","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.jacc.2010.02.025","article-title":"Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial","volume":"55","author":"Maisel","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.04.002_bib74","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.jacc.2008.07.042","article-title":"Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure","volume":"52","author":"Rehman","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.04.002_bib75","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jacc.2007.05.014","article-title":"Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro\u2013Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study","volume":"50","author":"Januzzi","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.04.002_bib76","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/eurjhf\/hfr087","article-title":"Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL Evaluation Along With B-Type Natriuretic Peptide in Acutely Decompensated Heart Failure (GALLANT) trial","volume":"13","author":"Maisel","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2013.04.002_bib77","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.cardfail.2011.02.003","article-title":"Renal dysfunction is a stronger determinant of systemic neutrophil gelatinase-associated lipocalin levels than myocardial dysfunction in systolic heart failure","volume":"17","author":"Shrestha","year":"2011","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2013.04.002_bib78","doi-asserted-by":"crossref","first-page":"R2","DOI":"10.1186\/cc10600","article-title":"Plasma neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury in acute heart failure","volume":"16","author":"Breidthardt","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.cardfail.2013.04.002_bib79","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1093\/eurjhf\/hfs087","article-title":"Elevated urinary neutrophil gelatinase-associated lipocalcin after acute heart failure treatment is associated with worsening renal function and adverse events","volume":"14","author":"Collins","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2013.04.002_bib80","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/eurjhf\/hfs039","article-title":"Lack of significant renal tubular injury despite acute kidney injury in acute decompensated heart failure","volume":"14","author":"Dupont","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2013.04.002_bib81","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1161\/CIRCHEARTFAILURE.110.960096","article-title":"Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study","volume":"4","author":"Maisel","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2013.04.002_bib82","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/eurjhf\/hfq091","article-title":"Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure","volume":"12","author":"Shah","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2013.04.002_bib83","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jacc.2006.03.061","article-title":"Utility of amino-terminal pro\u2013brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure","volume":"48","author":"van Kimmenade","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.04.002_bib84","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/CIRCHEARTFAILURE.111.965020","article-title":"Multiple biomarkers for risk prediction in chronic heart failure","volume":"5","author":"Ky","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2013.04.002_bib85","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/01.CIR.0000015464.18023.0A","article-title":"Multimarker approach to risk stratification in nonST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide","volume":"105","author":"Sabatine","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2013.04.002_bib86","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1056\/NEJMsa0803563","article-title":"Rehospitalizations among patients in the Medicare fee-for-service program","volume":"360","author":"Jencks","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2013.04.002_bib87","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/archinte.165.13.1469","article-title":"Adherence to heart failure quality-of-care indicators in US hospitals: analysis of the ADHERE registry","volume":"165","author":"Fonarow","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cardfail.2013.04.002_bib88","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jacc.2010.02.053","article-title":"Divergent trends in survival and readmission following a hospitalization for heart failure in the Veterans Affairs Health Care System 2002 to 2006","volume":"56","author":"Heidenreich","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.04.002_bib89","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJMc1001882","article-title":"Are all readmissions bad readmissions?","volume":"363","author":"Gorodeski","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2013.04.002_bib90","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/jama.297.1.61","article-title":"Association between performance measures and clinical outcomes for patients hospitalized with heart failure","volume":"297","author":"Fonarow","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2013.04.002_bib91","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MLR.0b013e3181ca3eb4","article-title":"Process of care performance measures and long-term outcomes in patients hospitalized with heart failure","volume":"48","author":"Patterson","year":"2010","journal-title":"Med Care"},{"key":"10.1016\/j.cardfail.2013.04.002_bib92","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1161\/CIRCULATIONAHA.111.026088","article-title":"The need for multiple measures of hospital quality: results from the Get With the Guidelines\u2013Heart Failure Registry of the American Heart Association","volume":"124","author":"Hernandez","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2013.04.002_bib93","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/CIRCOUTCOMES.110.959122","article-title":"Get With the Guidelines program participation, process of care, and outcome for medicare patients hospitalized with heart failure","volume":"5","author":"Heidenreich","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.cardfail.2013.04.002_bib94","doi-asserted-by":"crossref","first-page":"520","DOI":"10.7326\/0003-4819-155-8-201110180-00008","article-title":"Interventions to reduce 30-day rehospitalization: a systematic review","volume":"155","author":"Hansen","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cardfail.2013.04.002_bib95","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/1745-6215-12-194","article-title":"A meta-review of evidence on heart failure disease management programs: the challenges of describing and synthesizing evidence on complex interventions","volume":"12","author":"Savard","year":"2011","journal-title":"Trials"},{"key":"10.1016\/j.cardfail.2013.04.002_bib96","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1056\/NEJMoa1010029","article-title":"Telemonitoring in patients with heart failure","volume":"363","author":"Chaudhry","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2013.04.002_bib97","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.jacc.2012.03.013","volume":"59","author":"Bonow","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.04.002_bib98","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/jhm.563","article-title":"The paradox of readmission: effect of a quality improvement program in hospitalized patients with heart failure","volume":"5","author":"Mudge","year":"2010","journal-title":"J Hosp Med"},{"key":"10.1016\/j.cardfail.2013.04.002_bib99","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1001\/archinternmed.2007.83","article-title":"Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH)","volume":"168","author":"Jaarsma","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cardfail.2013.04.002_bib100","first-page":"810","article-title":"Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials","volume":"44","author":"McAlister","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.04.002_bib101","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.ahj.2004.09.023","article-title":"Metaanalysis and review of heart failure disease management randomized controlled clinical trials","volume":"149","author":"Whellan","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2013.04.002_bib102","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1001\/jama.2010.533","article-title":"Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure","volume":"303","author":"Hernandez","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2013.04.002_bib103","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.2011.836","article-title":"Improving postdischarge outcomes in patients hospitalized for acute heart failure syndromes","volume":"305","author":"Gheorghiade","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2013.04.002_bib104","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1056\/NEJMsa1101942","article-title":"The relationship between hospital admission rates and rehospitalizations","volume":"365","author":"Epstein","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2013.04.002_bib105","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jacc.2012.03.067","article-title":"Contemporary evidence about hospital strategies for reducing 30-day readmissions: a national study","volume":"60","author":"Bradley","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.04.002_bib106","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archinte.168.8.847","article-title":"Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF","volume":"168","author":"Fonarow","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cardfail.2013.04.002_bib107","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1553-2712.2011.01196.x","article-title":"Can junior emergency physicians use E-point septal separation to accurately estimate left ventricular function in acutely dyspneic patients?","volume":"18","author":"Secko","year":"2011","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.cardfail.2013.04.002_bib108","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1553-2712.2009.00630.x","article-title":"Diagnostic accuracy of emergency Doppler echocardiography for identification of acute left ventricular heart failure in patients with acute dyspnea: comparison with Boston criteria and N-terminal prohormone brain natriuretic peptide","volume":"17","author":"Nazerian","year":"2010","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.cardfail.2013.04.002_bib109","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ajem.2007.09.014","article-title":"Bedside ultrasound of the lung for the monitoring of acute decompensated heart failure","volume":"26","author":"Volpicelli","year":"2008","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.cardfail.2013.04.002_bib110","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ahj.2009.06.002","volume":"158","author":"Kamath","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2013.04.002_bib111","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1253\/circj.CJ-08-0847","article-title":"Whole body bioimpedance monitoring for outpatient chronic heart failure follow up","volume":"73","author":"Tanino","year":"2009","journal-title":"Circ J"},{"key":"10.1016\/j.cardfail.2013.04.002_bib112","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s11886-006-0031-0","article-title":"Impedance cardiography: more questions than answers","volume":"8","author":"Wang","year":"2006","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.cardfail.2013.04.002_bib113","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.cardfail.2011.11.001","article-title":"Differentiation of cardiac and noncardiac dyspnea using bioelectrical impedance vector analysis (BIVA)","volume":"18","author":"Piccoli","year":"2012","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2013.04.002_bib114","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ahj.2005.02.031","article-title":"A validated clinical and biochemical score for the diagnosis of acute heart failure: the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Acute Heart Failure Score","volume":"151","author":"Baggish","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2013.04.002_bib115","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.jacc.2009.05.065","article-title":"Improving the diagnosis of acute heart failure using a validated prediction model","volume":"54","author":"Steinhart","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.04.002_bib116","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jacc.2008.05.010","article-title":"Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis","volume":"52","author":"Maisel","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.04.002_bib117","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2010.05.020","article-title":"A\u00a0review of dyspnea in acute heart failure syndromes","volume":"160","author":"West","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2013.04.002_bib118","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/CIRCHEARTFAILURE.109.893222","article-title":"Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward","volume":"3","author":"Felker","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2013.04.002_bib119","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijcard.2010.04.003","article-title":"Acute heart failure: multiple clinical profiles and mechanisms require tailored therapy","volume":"144","author":"Metra","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cardfail.2013.04.002_bib120","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jacc.2003.07.031","article-title":"Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure","volume":"43","author":"Forman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.04.002_bib121","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/CIRCHEARTFAILURE.107.746933","article-title":"Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF)","volume":"1","author":"Klein","year":"2008","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2013.04.002_bib122","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejheart.2008.01.011","article-title":"Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance","volume":"10","author":"Metra","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2013.04.002_bib123","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","article-title":"Importance of venous congestion for worsening of renal function in advanced decompensated heart failure","volume":"53","author":"Mullens","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.04.002_bib124","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jacc.2008.08.080","article-title":"Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease","volume":"53","author":"Damman","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.04.002_bib125","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/CIRCHEARTFAILURE.111.961789","article-title":"Sympathetically mediated changes in capacitance: redistribution of the venous reservoir as a cause of decompensation","volume":"4","author":"Fallick","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2013.04.002_bib126","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1093\/eurheartj\/ehr238","article-title":"Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial","volume":"32","author":"Blair","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2013.04.002_bib127","doi-asserted-by":"crossref","first-page":"e540","DOI":"10.1161\/CIRCULATIONAHA.111.071696","article-title":"Heart failure with preserved ejection fraction","volume":"124","author":"Udelson","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2013.04.002_bib128","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jacc.2007.04.064","article-title":"Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry","volume":"50","author":"Fonarow","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.04.002_bib129","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1161\/CIRCULATIONAHA.109.909614","article-title":"Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial","volume":"121","author":"Zile","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2013.04.002_bib130","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.cardfail.2004.02.011","article-title":"Risk stratification after hospitalization for decompensated heart failure","volume":"10","author":"Felker","year":"2004","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2013.04.002_bib131","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ahj.2008.04.030","article-title":"Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF)","volume":"156","author":"O\u2019Connor","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2013.04.002_bib132","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jacc.2009.08.083","article-title":"Triage after hospitalization with advanced heart failure: the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge score","volume":"55","author":"O\u2019Connor","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.04.002_bib133","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/CIRCOUTCOMES.109.854877","article-title":"A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association Get With the Guidelines program","volume":"3","author":"Peterson","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.cardfail.2013.04.002_bib134","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.annemergmed.2007.07.026","article-title":"Validation of the Acute Heart Failure Index","volume":"51","author":"Hsieh","year":"2008","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.cardfail.2013.04.002_bib135","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.105.584102","article-title":"The Seattle Heart Failure Model: prediction of survival in heart failure","volume":"113","author":"Levy","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2013.04.002_bib136","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1161\/01.CIR.95.12.2660","article-title":"Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation","volume":"95","author":"Aaronson","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2013.04.002_bib137","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.healun.2011.05.012","article-title":"Selecting patients for heart transplantation: comparison of the Heart Failure Survival Score (HFSS) and the Seattle Heart Failure Model (SHFM)","volume":"30","author":"Goda","year":"2011","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.cardfail.2013.04.002_bib138","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1161\/CIRCOUTCOMES.110.958009","article-title":"Identifying patients hospitalized with heart failure at risk for unfavorable future quality of life","volume":"4","author":"Allen","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.cardfail.2013.04.002_bib139","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/eurjhf\/hfq132","article-title":"Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study","volume":"12","author":"Metra","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2013.04.002_bib140","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1093\/eurheartj\/ehr042","article-title":"Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT study","volume":"32","author":"Metra","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2013.04.002_bib141","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.jacc.2011.11.061","article-title":"Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow","volume":"59","author":"Ezekowitz","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.04.002_bib142","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1016\/j.jacc.2008.12.079","article-title":"End points for clinical trials in acute heart failure syndromes","volume":"53","author":"Allen","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.04.002_bib143","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/eurheartj\/ehr044","article-title":"Beyond dyspnoea as an endpoint in acute heart failure trials","volume":"32","author":"Gheorghiade","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2013.04.002_bib144","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1067\/mhj.2003.151","article-title":"Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure","volume":"145","author":"Teerlink","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2013.04.002_bib145","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1016\/j.jacc.2005.12.071","article-title":"Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure","volume":"47","author":"Packer","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.04.002_bib146","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1093\/eurheartj\/ehr050","article-title":"Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial","volume":"32","author":"Conraads","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2013.04.002_bib147","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1161\/CIRCULATIONAHA.111.043042","article-title":"Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure","volume":"124","author":"van Veldhuisen","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2013.04.002_bib148","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.jacc.2009.11.089","volume":"55","author":"Whellan","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.04.002_bib149","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1161\/CIRCULATIONAHA.108.800490","article-title":"Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure","volume":"121","author":"Ritzema","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2013.04.002_bib150","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.cardfail.2011.04.014","article-title":"Noninvasive monitoring of left ventricular end-diastolic pressure reduces rehospitalization rates in patients hospitalized for heart failure: a randomized controlled trial","volume":"17","author":"Sharma","year":"2011","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2013.04.002_bib151","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.cardfail.2011.07.007","article-title":"Hemodynamic monitoring to guide treatment of acute heart failure","volume":"17","author":"Givertz","year":"2011","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2013.04.002_bib152","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.jacc.2011.03.072","article-title":"Use of amino-terminal pro\u2013B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction","volume":"58","author":"Januzzi","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.04.002_bib153","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/CIRCOUTCOMES.110.957613","article-title":"National patterns of risk-standardized mortality and readmission for acute myocardial infarction and heart failure. Update on publicly reported outcomes measures based on the 2010 release","volume":"3","author":"Bernheim","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.cardfail.2013.04.002_bib154","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1527-5299.2005.03844.x","article-title":"Emergency department observation of heart failure: preliminary analysis of safety and cost","volume":"11","author":"Storrow","year":"2005","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.cardfail.2013.04.002_bib155","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jcin.2008.11.013","article-title":"Integration of pre-hospital electrocardiograms and ST-elevation myocardial infarction receiving center (SRC) networks: impact on Door-to-balloon times across 10 independent regions","volume":"2","author":"Rokos","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cardfail.2013.04.002_bib156","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/CIRCOUTCOMES.108.802686","article-title":"An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure","volume":"1","author":"Keenan","year":"2008","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.cardfail.2013.04.002_bib157","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/S0735-1097(99)00059-5","article-title":"Prediction of hospital readmission for heart failure: development of a simple risk score based on administrative data","volume":"33","author":"Philbin","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.04.002_bib158","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/MAT.0b013e3182223269","article-title":"Ethical considerations for ventricular assist device support: a 10-point model","volume":"57","author":"Petrucci","year":"2011","journal-title":"ASAIO J"},{"key":"10.1016\/j.cardfail.2013.04.002_bib159","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.athoracsur.2011.07.084","article-title":"The ethics of mechanical support: the need for new guidelines","volume":"92","author":"Entwistle","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cardfail.2013.04.002_bib160","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jacc.2009.02.078","article-title":"Palliative care in congestive heart failure","volume":"54","author":"Goodlin","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.04.002_bib161","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.cardfail.2012.10.019","article-title":"Examining the effects of an outpatient palliative care consultation on symptom burden, depression, and quality of life in patients with symptomatic heart failure","volume":"18","author":"Evangelista","year":"2012","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2013.04.002_bib162","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/eurjhf\/hfq209","article-title":"Rationale and design of the multicentre, randomized, double-blind, placebo-controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT)","volume":"13","author":"Gheorghiade","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2013.04.002_bib163","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1001\/jama.2013.1954","article-title":"Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial","volume":"309","author":"Gheorghiade","year":"2013","journal-title":"JAMA"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916413001206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916413001206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:41:50Z","timestamp":1761028910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916413001206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":163,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S1071916413001206"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2013.04.002","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute Decompensated Heart Failure: Update on New and Emerging Evidence and Directions for Future Research","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2013.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}